Biotech Investing Immix Biopharma Announces Pricing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Biotech Investing At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
Biotech Investing New Data from the Phase II ARCHER Trial Demonstrate CardiolRx Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
Biotech Investing BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
Biotech Investing Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry
Biotech Investing Cizzle Brands Places CWENCH Hydration and HappiEats Sport Pasta at 91 Popeye's Supplements Canada Locations
Biotech Investing Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040
Biotech Investing Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate HighlightsÂ
Tartisan Nickel Corp. Announces Rodren Drilling has Commenced Drilling at the Kenbridge Nickel Copper Cobalt Project, Sioux Narrows, Northwestern, Ontario
Momentum Builds, Upside Appears as Mining Explorers Transition Toward Production, Unlock Major Hidden Value
